日本語English简体中文 繁體中文

190A Chordia Therapeutics Inc.Chordia TherapeuticsTSE Growth / Pharmaceuticals

0 posts

Chordia Therapeutics Inc. stock rose on Nov 19: what happened

It closed at ¥45.0 on Nov 19 (+¥4.0, +9.76%), ranking #15 among the top gainers of all stocks on the Tokyo Stock Exchange.

No disclosures were found for this stock around that day. Share what you know in the posts below.

Changes are calculated from the closing prices this site collects daily; limit-up/down is an estimate based on the daily price limit. Please make your own investment decisions.

Chordia Therapeutics Inc. (190A) at a glance

Code
190A
Company
Chordia Therapeutics Inc.
Local name
Chordia Therapeutics
Market
TSE Growth
Sector
Pharmaceuticals
Share price
¥45.0 +4.00 (+9.76%) Nov 19 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Chordia Therapeutics Inc. (190A) Stock Price History

Chordia Therapeutics Inc. closed at ¥45.0 on Nov 19, 2026, −19.6% over 1 month, −55.4% over 1 year.

¥56.0¥41.0Oct 19Nov 19
Price5-day MA25-day MANikkei 225
1-Month High¥56.0Oct 19
1-Month Low¥41.0Nov 18
1-Week Change+0.0%vs Nov 12
1-Month Change−19.6%vs Oct 19

If you had invested ¥100,000 1 month ago, it would be worth ¥80,357 today (−19.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −8.4%, while this stock moved −19.6%.

Last 10 Trading Days

DateCloseChange% Change
Nov 19 (Thu)¥45.0+4+9.76%
Nov 18 (Wed)¥41.0−2−4.65%
Nov 17 (Tue)¥43.0−1−2.27%
Nov 16 (Mon)¥44.0−2−4.35%
Nov 13 (Fri)¥46.0+1+2.22%
Nov 12 (Thu)¥45.0+0+0.00%
Nov 11 (Wed)¥45.0+1+2.27%
Nov 10 (Tue)¥44.0+0+0.00%
Nov 9 (Mon)¥44.0+2+4.76%
Nov 6 (Fri)¥42.0−3−6.67%
2026-09-09 第9回新株予約権(行使価額修正条項付)の取得及び消却の完了に関するお知らせ / 第三者割当による行使価額修正条項付第12回新株予約権(停止指定条項付)の発行に係…2026-10-15 2026年8月期 決算短信〔日本基準〕(非連結)¥82.0¥41.0Aug 19Nov 19
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥82.0Aug 20
3-Month Low¥41.0Nov 18
1-Month Change−19.6%vs Oct 19
3-Month Change−43.8%vs Aug 19

If you had invested ¥100,000 3 months ago, it would be worth ¥56,250 today (−43.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −9.0%, while this stock moved −43.8%.

Last 10 Trading Days

DateCloseChange% Change
Nov 19 (Thu)¥45.0+4+9.76%
Nov 18 (Wed)¥41.0−2−4.65%
Nov 17 (Tue)¥43.0−1−2.27%
Nov 16 (Mon)¥44.0−2−4.35%
Nov 13 (Fri)¥46.0+1+2.22%
Nov 12 (Thu)¥45.0+0+0.00%
Nov 11 (Wed)¥45.0+1+2.27%
Nov 10 (Tue)¥44.0+0+0.00%
Nov 9 (Mon)¥44.0+2+4.76%
Nov 6 (Fri)¥42.0−3−6.67%
2026-09-09 第9回新株予約権(行使価額修正条項付)の取得及び消却の完了に関するお知らせ / 第三者割当による行使価額修正条項付第12回新株予約権(停止指定条項付)の発行に係…2026-10-15 2026年8月期 決算短信〔日本基準〕(非連結)¥117¥41.0May 19Nov 19
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥117May 19
6-Month Low¥41.0Nov 18
3-Month Change−43.8%vs Aug 19
6-Month Change−61.5%vs May 19

If you had invested ¥100,000 6 months ago, it would be worth ¥38,462 today (−61.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −1.8%, while this stock moved −61.5%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥45.0−8.2%
Oct 2026¥49.0−29.0%
Sep 2026¥69.0−6.8%
Aug 2026¥74.0−5.1%
Jul 2026¥78.0+2.6%
Jun 2026¥76.0−30.3%
May 2026¥109−27.3%
2026-09-09 第9回新株予約権(行使価額修正条項付)の取得及び消却の完了に関するお知らせ / 第三者割当による行使価額修正条項付第12回新株予約権(停止指定条項付)の発行に係…2026-10-15 2026年8月期 決算短信〔日本基準〕(非連結)¥167¥41.0Nov 19Nov 19
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥167Feb 27
52-Week Low¥41.0Nov 18
Year to Date−58.3%vs Dec 30
From 52-Week High−73.1%Feb 27

If you had invested ¥100,000 1 year ago, it would be worth ¥44,554 today (−55.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +22.5%, while this stock moved −55.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥45.0−8.2%
Oct 2026¥49.0−29.0%
Sep 2026¥69.0−6.8%
Aug 2026¥74.0−5.1%
Jul 2026¥78.0+2.6%
Jun 2026¥76.0−30.3%
May 2026¥109−27.3%
Apr 2026¥150+22.0%
Mar 2026¥123−26.3%
Feb 2026¥167+35.8%
Jan 2026¥123+13.9%
Dec 2025¥108+2.9%
Nov 2025¥105―
¥831¥42.0Jun 10, 2024Nov 19, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥831Aug 12, 2024
3-Year Low¥42.0Nov 6, 2026
Annualized Return−44.8%
Max Drawdown−94.9%

If you had invested ¥100,000 3 years ago, it would be worth ¥23,438 today (−76.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +53.1%, while this stock moved −76.6%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥45.0−58.3%
2025¥108―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jun 2024). Please check the latest prices before trading.

Chordia Therapeutics Inc. (190A) financial indicators

PBR
1.81
Dividend yield
0.00%

See all financial indicators for Chordia Therapeutics Inc. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of Chordia Therapeutics Inc. (190A)

Business overview

The company is a drug discovery venture conducting R&D aimed at bringing new anticancer drugs to market. Its main business is researching and developing first-in-class small-molecule drugs with new mechanisms of action in cancer, an area of high medical need. The company concentrates on management and research work such as searching for, evaluating and optimizing candidate compounds and running clinical trials, while outsourcing basic research, manufacturing of drug substances and products, and distribution and sales to external partners. It actively pursues joint research and licensing with universities, public institutions, pharmaceutical companies and others to create new drugs efficiently. Its basic partnering strategy is to negotiate rights to sell outside Japan once the results of Phase 2 trials, considered the least likely to succeed, are available and the likelihood of reaching the market has increased.

Summarized from the annual securities report (fiscal year ended August 2025) filed on EDINET.

Position within Pharmaceuticals (79 companies)

PBR1.81xBelow the sector median of 1.87x (No. 37 from the lowest)
Market cap¥3.5 bnNo. 68 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥1672/27
52-week low¥4111/18
Current position3.2%Where the low is 0% and the high is 100% (close on 11/19: ¥45)
Year to date-58.3%No. 75 of 77 in the sector (best first)
1 year-55.5%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 gainers1 timesLatest: 11/19 (No. 15)
Top 50 losers1 timesLatest: 10/1 (No. 36)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/19 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (10).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Chordia Therapeutics Inc. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English